GlaxoSmithKline (GSK; NYSE: GSK), a leading global vaccine manufacturer, has signed an agreement with Philippines-based Zuellig Pharma to provide warehousing and distribution services, with a focus on cold-chain management for GSK’s vaccines in Singapore. This strategic partnership will establish a vaccine distribution hub serving 13 markets across the Asia-Pacific region.
Cold-Chain Management and Blockchain Technology Integration
Under the terms of the deal, Zuellig Pharma will also provide its eZTracker blockchain technology-based product tracker, offering an end-to-end product traceability platform for GSK. This integration will enhance the transparency and efficiency of GSK’s vaccine supply chain, ensuring the quality and safety of vaccines reach their destinations.
GSK’s Global Vaccine Leadership and Impact
GSK is recognized as the largest vaccine producer worldwide, with a product portfolio that includes vaccines for meningitis, shingles, flu, polio, measles, and more. The company supplies an impressive 2 million vaccines daily, and approximately 40% of the world’s children receive a GSK-made vaccine each year. This partnership with Zuellig Pharma is set to bolster GSK’s distribution capabilities and further its mission to improve global health outcomes.-Fineline Info & Tech
